Acquisition of methicillin-resistant Staphylococcus aureus (MRSA) in contacts of patients newly identified as colonized or infected with MRSA in the immediate postexposure and postdischarge periods

American Journal of Infection Control

Volumn 45, Issue 3, 2017, Pages 295-297

  Williams, Victoria R ^a   Callery, Sandra ^a   Vearncombe, Mary ^a,b   Simor, Andrew E ^a,b  

^a SUNNYBROOK RESEARCH INSTITUTE   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

Contact; Methicillin resistant Staphylococcus aureus; Surveillance screening

Indexed keywords

ADULT; ARTICLE; BACTERIUM COLONY; BACTERIUM CULTURE; BACTERIUM IDENTIFICATION; CONTROLLED STUDY; DISEASE SURVEILLANCE; EMERGENCY CARE; FEMALE; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HUMAN; MAJOR CLINICAL STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; PROGRAM APPROPRIATENESS; TEACHING HOSPITAL; TERTIARY HEALTH CARE; COMMUNITY ACQUIRED INFECTION; DISEASE TRANSMISSION; EPIDEMIOLOGICAL MONITORING; HETEROZYGOTE; ISOLATION AND PURIFICATION; MICROBIOLOGY; STAPHYLOCOCCUS INFECTION; TRANSMISSION;

CARRIER STATE; COMMUNITY-ACQUIRED INFECTIONS; DISEASE TRANSMISSION, INFECTIOUS; EPIDEMIOLOGICAL MONITORING; HUMANS; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCAL INFECTIONS;

EID: 85005896424     PISSN: 01966553     EISSN: 15273296     Source Type: Journal    
DOI: 10.1016/j.ajic.2016.09.009     Document Type: Article

References (7)

1. 1 Public Health Agency of Canada, Methicillin-resistant Staphylococcus aureus in Canadian acute-care hospitals: surveillance report January 1, 2008 to December 31, 2012. 2014, Centre for Communicable Diseases and Infection Control, Public Health Agency of Canada, Ottawa, Ontario (Canada).
2. 2 Dantes, R., Mu, Y., Belflower, R., Aragon, D., Dumyati, G., Harrison, L.H., et al. National burden of invasive methicillin-resistant Staphylococcus aureus infections, United States, 2011. JAMA Intern Med 173 (2013), 1970–1978.
3. 3 Geffers, C., Farr, B.M., Risk of transmission of nosocomial methicillin-resistant Staphylococcus aureus (MRSA) from patients colonized with MRSA. Infect Control Hosp Epidemiol 26 (2005), 114–115.
4. 4 Siegel, J.D., Rhinehart, E., Jackson, M., Chiarello, L., Healthcare Infection Control Practices Advisory Committee. Management of multidrug-resistant organisms in health care settings, 2006. Am J Infect Control 35:Suppl (2007), S165–93.
5. 5 Ontario Agency for Health Protection and Promotion, Provincial Infectious Diseases Advisory Committee, Annex A—screening, testing and surveillance for antibiotic-resistant organisms (AROs). Annexed to: routine practices and additional precautions in all health care settings, 2013, Queen's Printer for Ontario, Toronto, ON, Canada, 11–13.
6. 6 Mulvey, M.R., Chui, L., Ismail, J., Louie, L., Murphy, C., Chang, N., et al. Development of a Canadian standardized protocol for subtyping methicillin-resistant Staphylococcus aureus using pulsed-field gel electrophoresis. J Clin Microbiol 39 (2001), 3481–3485.
7. 7 Moore, C., Dhaliwal, J., Tong, A., Eden, S., Wigston, C., Willey, B., et al. Risk factors for methicillin-resistant Staphylococcus aureus (MRSA) acquisition in roommate contacts of patients colonized or infected with MRSA in an acute-care hospital. Infect Control Hosp Epidemiol 29 (2008), 600–606.